William Blair reissued their outperform rating on shares of P3 Health Partners (NASDAQ:PIII - Free Report) in a research note published on Monday, RTT News reports.
A number of other research firms have also weighed in on PIII. BTIG Research lowered shares of P3 Health Partners from a buy rating to a neutral rating in a research report on Monday. Lake Street Capital decreased their price target on shares of P3 Health Partners from $9.00 to $4.50 and set a buy rating on the stock in a research note on Thursday, March 14th.
View Our Latest Stock Analysis on P3 Health Partners
P3 Health Partners Stock Performance
NASDAQ PIII traded down $0.15 during trading hours on Monday, hitting $0.88. 416,470 shares of the company's stock traded hands, compared to its average volume of 381,953. The business's fifty day moving average price is $1.06 and its two-hundred day moving average price is $1.27. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $277.02 million, a P/E ratio of -1.36 and a beta of 1.04. P3 Health Partners has a 52 week low of $0.66 and a 52 week high of $5.56.
Institutional Investors Weigh In On P3 Health Partners
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Moneta Group Investment Advisors LLC purchased a new position in P3 Health Partners in the 4th quarter worth about $119,579,000. Ameriprise Financial Inc. grew its holdings in P3 Health Partners by 108.6% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,439,857 shares of the company's stock worth $7,997,000 after acquiring an additional 2,831,604 shares in the last quarter. Vanguard Group Inc. grew its holdings in P3 Health Partners by 13.5% during the 1st quarter. Vanguard Group Inc. now owns 2,430,062 shares of the company's stock worth $19,003,000 after acquiring an additional 289,504 shares in the last quarter. BlackRock Inc. grew its holdings in P3 Health Partners by 50.2% during the 2nd quarter. BlackRock Inc. now owns 2,376,934 shares of the company's stock worth $7,107,000 after acquiring an additional 794,818 shares in the last quarter. Finally, Emfo LLC grew its holdings in P3 Health Partners by 7.9% during the 3rd quarter. Emfo LLC now owns 1,004,147 shares of the company's stock worth $1,476,000 after acquiring an additional 73,725 shares in the last quarter. Hedge funds and other institutional investors own 7.75% of the company's stock.
About P3 Health Partners
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Read More
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
